ENOV

Enovis Corporation NYQ · ENOV

$27.07 -1.00 (-3.56%)

Extended · +1.56σ Grade C

+ Compare Open in Sniper

Valuation

Market cap $1.6B

P/E (ttm) —

Forward P/E 6.6

Beta (5y) 1.50

Shares out 57.6M

Div yield —

Profitability & returns

ROE -55.3%

Net margin -49.9%

FCF margin 9.1%

Debt / equity 0.95

Trading information

Last price $27.07

Day range $26.48 – $28.69

52-wk range $19.14 – $28.69

Avg volume 1.2M

RSI (2) 56.1

Trend zone Extended

52-week range · today's price

$19.14$28.69

Company

Sector Healthcare

Industry Medical Devices

Exchange NYQ

Next earnings 2026-08-06

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electr…